Published in Antimicrob Agents Chemother on July 01, 1994
Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection | NCT00388167
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol (1998) 7.01
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother (1997) 5.76
Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother (1997) 4.87
Resistance to echinocandin-class antifungal drugs. Drug Resist Updat (2007) 4.63
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (1997) 4.14
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother (2001) 3.28
Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother (1996) 3.03
Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob Agents Chemother (1994) 2.99
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol (2003) 2.89
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother (2002) 2.76
Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob Agents Chemother (2001) 2.65
Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis (2008) 2.63
The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother (2002) 2.60
Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother (2005) 2.54
Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother (2000) 2.51
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob Agents Chemother (1997) 2.51
In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother (1995) 2.37
A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase. J Bacteriol (1994) 2.33
Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia. Antimicrob Agents Chemother (2002) 2.30
Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus. Antimicrob Agents Chemother (2003) 2.27
Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrob Agents Chemother (2007) 2.18
Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity. Antimicrob Agents Chemother (2005) 2.07
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother (1998) 2.00
Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol (2003) 1.89
Treatment of murine disseminated candidiasis with L-743,872. Antimicrob Agents Chemother (1997) 1.87
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother (2007) 1.85
Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein. J Bacteriol (1996) 1.82
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis (2008) 1.82
Fungal echinocandin resistance. Fungal Genet Biol (2009) 1.78
Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother (2007) 1.77
Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis. Antimicrob Agents Chemother (1995) 1.75
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother (2002) 1.72
Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog (2007) 1.64
Combination treatment of invasive fungal infections. Clin Microbiol Rev (2005) 1.59
Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals. Antimicrob Agents Chemother (2004) 1.58
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother (2008) 1.55
Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob Agents Chemother (2007) 1.54
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother (2004) 1.46
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling. Antimicrob Agents Chemother (2001) 1.45
Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob Agents Chemother (2001) 1.45
Current perspectives on echinocandin class drugs. Future Microbiol (2011) 1.44
A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob Agents Chemother (2007) 1.44
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrob Agents Chemother (2007) 1.31
Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother (2002) 1.27
Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. PLoS One (2010) 1.26
Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Clin Microbiol Infect Dis (2004) 1.23
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother (2008) 1.21
Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiae. Antimicrob Agents Chemother (2009) 1.19
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother (2003) 1.17
Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother (2008) 1.17
Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species. Antimicrob Agents Chemother (2006) 1.16
Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob Agents Chemother (2002) 1.14
Organization and dynamics of the Aspergillus nidulans Golgi during apical extension and mitosis. Mol Biol Cell (2009) 1.12
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother (2009) 1.11
Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother (2005) 1.09
Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis (2008) 1.05
Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy. Eur J Clin Microbiol Infect Dis (2004) 1.02
Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother (2001) 1.02
In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp. Antimicrob Agents Chemother (2005) 1.00
Differential Aspergillus lentulus echinocandin susceptibilities are Fksp independent. Antimicrob Agents Chemother (2010) 0.99
Comparison of echinocandin antifungals. Ther Clin Risk Manag (2007) 0.99
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother (2003) 0.98
Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol (2003) 0.97
LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability. Antimicrob Agents Chemother (1999) 0.96
Coccidioides posadasii contains a single 1,3-beta-glucan synthase gene that appears to be essential for growth. Eukaryot Cell (2005) 0.94
Conidial viability assay for rapid susceptibility testing of Aspergillus species. J Clin Microbiol (2002) 0.93
Discovery of a novel class of orally active antifungal beta-1,3-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2011) 0.93
Antifungal therapy of murine Aspergillus terreus infection. Antimicrob Agents Chemother (2004) 0.91
The composition of the culture medium influences the β-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of β-1,3-glucan synthesis. Antimicrob Agents Chemother (2012) 0.91
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia. Antimicrob Agents Chemother (2010) 0.90
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation. Antimicrob Agents Chemother (2003) 0.89
Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infections. Antimicrob Agents Chemother (2010) 0.88
Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother (2003) 0.88
Genomics-driven discovery of the pneumocandin biosynthetic gene cluster in the fungus Glarea lozoyensis. BMC Genomics (2013) 0.88
In vitro antifungal susceptibilities of uncommon basidiomycetous yeasts. Antimicrob Agents Chemother (2004) 0.87
Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate. Clin Diagn Lab Immunol (2005) 0.86
Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harb Perspect Med (2014) 0.85
Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs. Med Mycol (2008) 0.85
Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration. J Clin Microbiol (2009) 0.84
New methods to assess susceptibilities of Aspergillus isolates to caspofungin. J Clin Microbiol (2003) 0.84
Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis. Antimicrob Agents Chemother (2005) 0.81
Effect of fluid loading during hypovolaemic shock on caspofungin pharmacokinetic parameters in pig. Crit Care (2011) 0.81
Pharmacological assessment of the medicinal potential of Acacia mearnsii De Wild.: antimicrobial and toxicity activities. Int J Mol Sci (2012) 0.81
Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111. J Clin Microbiol (2015) 0.80
Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies. Antimicrob Agents Chemother (2015) 0.80
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (2012) 0.79
Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopy. Antimicrob Agents Chemother (2007) 0.78
MaFKS, a β-1,3-glucan synthase, is involved in cell wall integrity, hyperosmotic pressure tolerance and conidiation in Metarhizium acridum. Curr Genet (2011) 0.78
Cellular accumulation, localization, and activity of a synthetic cyclopeptamine in fungi. Antimicrob Agents Chemother (1998) 0.77
Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro. Antimicrob Agents Chemother (2002) 0.77
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis. Infect Drug Resist (2009) 0.76
Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs. Antimicrob Agents Chemother (2015) 0.76
In vitro activity of A-192411.29, a novel antifungal lipopeptide. Antimicrob Agents Chemother (2000) 0.75
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae. Antimicrob Agents Chemother (2015) 0.75
Neutrophil Interactions Stimulate Evasive Hyphal Branching by Aspergillus fumigatus. PLoS Pathog (2017) 0.75
Creation, characterization and utilization of Cryptococcus neoformans mutants sensitive to micafungin. Curr Genet (2017) 0.75
Caspofungin-Mediated Growth Inhibition and Paradoxical Growth in Aspergillus fumigatus involve Fungicidal Hyphal Tip Lysis Coupled with Regenerative Intrahyphal Growth and Dynamic Changes in β-1,3-Glucan Synthase Localization. Antimicrob Agents Chemother (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol (1992) 12.13
Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol (1968) 8.41
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother (1993) 8.36
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84
In vitro and in vivo anti-Candida activity and toxicology of LY121019. J Antibiot (Tokyo) (1984) 3.68
Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives. J Med Chem (1994) 3.52
Protoplasmic organization of hyphal tips among fungi: vesicles and Spitzenkörper. J Bacteriol (1970) 3.24
Biosynthesis of the yeast cell wall. I. Preparation and properties of beta-(1 leads to 3)glucan synthetase. J Biol Chem (1980) 2.77
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin. Antimicrob Agents Chemother (1992) 2.39
Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. Proc Natl Acad Sci U S A (1990) 2.37
Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia (1981) 2.32
Echinocandin inhibition of 1,3-beta-D-glucan synthase from Candida albicans. FEBS Lett (1984) 2.07
In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis (1990) 2.06
Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J Antibiot (Tokyo) (1992) 2.02
Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity. Antimicrob Agents Chemother (1988) 1.89
Fungal 1,3-beta-glucan synthase. Methods Enzymol (1987) 1.88
Biosynthesis of the yeast cell wall. II. Regulation of beta-(1 leads to 3)glucan synthetase by ATP and GTP. J Biol Chem (1980) 1.81
Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic. Ann N Y Acad Sci (1988) 1.75
Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase. FEMS Microbiol Lett (1993) 1.74
Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrob Agents Chemother (1991) 1.61
Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats. Antimicrob Agents Chemother (1992) 1.57
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019. Diagn Microbiol Infect Dis (1988) 1.57
Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan. J Bacteriol (1992) 1.54
LY121019 inhibits Neurospora crassa growth and (1-3)-beta-D-glucan synthase. J Antibiot (Tokyo) (1988) 1.53
(1,3)-beta-D-Glucan synthase from budding and filamentous cultures of the dimorphic fungus Candida albicans. Eur J Biochem (1982) 1.50
Stimulation of beta(1----3)glucan synthetase of various fungi by nucleoside triphosphates: generalized regulatory mechanism for cell wall biosynthesis. J Bacteriol (1985) 1.38
W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase. Antimicrob Agents Chemother (1991) 1.25
Characterization of the 1,3-beta-glucan synthase of Aspergillus fumigatus. J Gen Microbiol (1993) 1.23
The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicans. Can J Microbiol (1984) 1.22
L-671,329, a new antifungal agent. II. Structure determination. J Antibiot (Tokyo) (1989) 1.14
Effect of papulacandin B on glucan synthesis in Paracoccidioides brasiliensis. J Med Vet Mycol (1986) 1.12
Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy. J Med Vet Mycol (1990) 1.12
Fungal cell wall synthesis and assembly. Curr Top Med Mycol (1989) 0.99
Nuclear migration in a nud mutant of Aspergillus nidulans is inhibited in the presence of a quantitatively normal population of cytoplasmic microtubules. J Cell Biol (1988) 0.96
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (1997) 4.14
Rhizobium meliloti genes required for nodule development are related to chromosomal virulence genes in Agrobacterium tumefaciens. Proc Natl Acad Sci U S A (1986) 3.38
Primary structures and catalytic properties of isoenzymes encoded by the two 4-coumarate: CoA ligase genes in parsley. Eur J Biochem (1988) 3.05
Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob Agents Chemother (1994) 2.99
Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry (1986) 2.52
General outbreaks of infectious intestinal disease in England and Wales: 1995 and 1996. Commun Dis Public Health (1998) 2.35
A unified hypothesis for the role of membrane bound enzyme complexes and microtubules in plant cell wall synthesis. J Theor Biol (1974) 2.30
Isolation of hem3 mutants from Candida albicans by sequential gene disruption. Mol Gen Genet (1989) 2.26
Mitosis in the fungus Thraustotheca clavata. J Cell Biol (1974) 2.15
Argon laser iridotomy in the treatment of patients with primary angle-closure or pupillary block glaucoma: a clinicopathologic study. Ophthalmology (1978) 1.82
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2000) 1.66
The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. Clin Oncol (R Coll Radiol) (2013) 1.66
Ion channel activity and tip growth: tip-localized stretch-activated channels generate an essential Ca2+ gradient in the oomycete Saprolegnia ferax. Eur J Cell Biol (1993) 1.55
Assay of corticotropin releasing factor. Methods Enzymol (1983) 1.53
Roles of calcium ions in hyphal tip growth. Microbiol Rev (1993) 1.48
Ultrastructure of mitosis in the cowpea rust fungus Uromyces phaseoli var. Vignae. J Cell Biol (1976) 1.47
Behavior of kinetochores during mitosis in the fungus Saprolegnia ferax. J Cell Biol (1980) 1.31
The roles of Ca2+ and plasma membrane ion channels in hyphal tip growth of Neurospora crassa. J Cell Sci (1995) 1.31
Variant mitoses in lower eukaryotes: indicators of the evolution of mitosis. Int Rev Cytol (1980) 1.24
Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature (1978) 1.21
Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev (2008) 1.18
Mitosis in the fungus Zygorhynchus moelleri: evidence for stage specific enhancement of microtubule preservation by freeze substitution. Eur J Cell Biol (1982) 1.15
The arrangement of microtubules in serially sectioned spindles of the alga Cryptomonas. J Cell Sci (1978) 1.15
Factors Affecting Crown Gall Tumorigenesis in Tuber Slices of Jerusalem Artichoke (Helianthus tuberosus, L.). Plant Physiol (1979) 1.14
A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry (1999) 1.14
Women's Evaluation of Intrapartum Nonpharmacological Pain Relief Methods Used during Labor. J Perinat Educ (2001) 1.10
The effects of tannic acid on the in vivo preservation of microfilaments. Eur J Cell Biol (1979) 1.09
Anatomic and phylogenetic distribution of somatostatin. Metabolism (1976) 1.08
Ultrastructural observations on the kinetosomes, and golgi bodies during the asexual life cycle of Saprolegnia. Z Zellforsch Mikrosk Anat (1971) 1.00
Housing environments and community adjustment of severely mentally ill persons. Community Ment Health J (1990) 1.00
The possible significance of variations in the mitotic systems of the aquatic fungi (Phycomycetes). Biosystems (1975) 0.99
The effect of antimicrotubule agents on the growth and ultrastructure of the fungus Saprolegnia ferax and their ineffectiveness in disrupting hyphal microtubules. Protoplasma (1975) 0.98
Terminal illness: views of patients and their lay carers. Palliat Med (1995) 0.98
Specific attachment of Agrobacterium tumefaciens to bamboo cells in suspension cultures. J Bacteriol (1985) 0.97
Amerindian pyruvate carboxylase deficiency is associated with two distinct missense mutations. Am J Hum Genet (1998) 0.96
Nuclear migration in a nud mutant of Aspergillus nidulans is inhibited in the presence of a quantitatively normal population of cytoplasmic microtubules. J Cell Biol (1988) 0.96
Cytoskeletal regulation of ion channel distribution in the tip-growing organism Saprolegnia ferax. J Cell Sci (1994) 0.96
L-657,398, a novel antifungal agent: fermentation, isolation, structural elucidation and biological properties. J Antibiot (Tokyo) (1988) 0.95
Nuclear cycle of Saprolegnia ferax. J Cell Sci (1981) 0.95
Microtubules and organelle movements in the rust fungus Uromyces phaseoli var. vignae. Cytobiologie (1978) 0.94
Serological evidence of dengue fever among refugees, Hargeysa, Somalia. J Med Virol (1989) 0.92
The molecular physiology of poplars: paving the way for knowledge-based biomass production. Plant Biol (Stuttg) (2010) 0.91
Establishing long-term survival and cure in young patients with Ewing's sarcoma. Br J Cancer (2004) 0.91
Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase. J Biol Chem (1998) 0.91
Integrin and spectrin homologues, and cytoplasm-wall adhesion in tip growth. J Cell Sci (1995) 0.90
Pharmacokinetics of L-671,329 in rhesus monkeys and DBA/2 mice. Antimicrob Agents Chemother (1992) 0.89
Interrelationships between cytoplasmic Ca2+ peaks, pollen hydration and plasma membrane conductances during compatible and incompatible pollinations of Brassica napus papillae. Plant Cell Physiol (1997) 0.89
Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms. Int Microbiol (2001) 0.88
Value of screening for markers of hepatitis in dialysis units. Hepatology (1983) 0.88
Cytoskeletal and Ca2+ regulation of hyphal tip growth and initiation. Curr Top Dev Biol (2001) 0.88
N-terminal extension changes the folding mechanism of the FK506-binding protein. Protein Sci (2001) 0.87
Ultrastructural description of a new chytrid genus of caecum anaerobe, Caecomyces equi gen. nov., sp. nov., assigned to the Neocallimasticaceae. Biosystems (1988) 0.87
Mapping irradiation hybrids to cosmid and yeast artificial chromosome libraries by direct hybridization of Alu-PCR products. Nucleic Acids Res (1991) 0.86
Effects of chest physical therapy on lung function in children recovering from acute severe asthma. Pediatr Pulmonol (1990) 0.86
Viridiofungins, novel inhibitors of sphingolipid synthesis. J Antibiot (Tokyo) (1997) 0.86
Measurement of salivary immunoglobulin A as an immunologic biomarker of job stress. Scand J Work Environ Health (1992) 0.85
Mucopolysaccharides in urine during normal human development. Pediatr Res (1973) 0.85
The origin of Flimmer in Saprolegnia, Dictyuchus, Synura and Cryptomonas. J Cell Sci (1970) 0.84
Lung volumes in Polynesian children. Am Rev Respir Dis (1987) 0.84
Measuring mechanosensitive channels in uromyces. Science (1992) 0.84
Geranylgeranyltransferase I of Candida albicans: null mutants or enzyme inhibitors produce unexpected phenotypes. J Bacteriol (2000) 0.84
Colchicine and colcemid binding components of the fungus Saprolegnia ferax. Protoplasma (1975) 0.83
Mapping surgical coordinates of the sphenopalatine foramen: surgical navigation study. J Laryngol Otol (2009) 0.82
An electron microscopic and spectroscopic study of murine epiphyseal cartilage: analysis of fine structure and matrix vesicles preserved by slam freezing and freeze substitution. J Ultrastruct Mol Struct Res (1988) 0.82
A putative spectrin-containing membrane skeleton in hyphal tips of Neurospora crassa. Fungal Genet Biol (2000) 0.82
cDNA cloning of human kidney pyruvate carboxylase. Biochem Biophys Res Commun (1994) 0.81
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. Br J Cancer (2005) 0.81
Screening for psychiatric symptoms: PAS-ADD Checklist norms for adults with intellectual disabilities. J Intellect Disabil Res (2004) 0.80
Smell identification test as an indicator for cognitive impairment in Alzheimer's disease. Int J Geriatr Psychiatry (2004) 0.80
Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum. J Appl Microbiol (2001) 0.80
The changing distribution of actin and nuclear behavior during the cell cycle of the mite-pathogenic fungus Neozygites sp. Eur J Cell Biol (1988) 0.79
Radial F-actin arrays precede new hypha formation in Saprolegnia: implications for establishing polar growth and regulating tip morphogenesis. J Cell Sci (1998) 0.79
Empirically selected instruments for measuring quality-of-life dimensions in culturally diverse populations. J Natl Cancer Inst Monogr (1996) 0.79
Basal body loss during fungal zoospore encystment: evidence against centriole autonomy. J Cell Sci (1986) 0.78
Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum. Behav Brain Res (1997) 0.78
Restricticin, a novel glycine-containing antifungal agent. J Antibiot (Tokyo) (1991) 0.78
Long-term respiratory support in children with giant omphalocele. Anaesth Intensive Care (2007) 0.78
Tillage, crop rotation, and organic amendment effect on changes in soil organic matter. Environ Pollut (2002) 0.78
Development of a Portable Acceleration Monitor Device and its clinical application for the Quantitative Gait Assessment of the Elderly. Conf Proc IEEE Eng Med Biol Soc (2005) 0.77
Ca(2+) shuttling in vesicles during tip growth in Neurospora crassa. Fungal Genet Biol (2001) 0.77
Nitric oxide levels and ciliary beat frequency in indigenous New Zealand children. Pediatr Pulmonol (2005) 0.77
[Effect of fat-controlled nutrition on patients with coronary diseases]. Med Welt (1965) 0.76
A tip-high gradient of a putative plasma membrane SNARE approximates the exocytotic gradient in hyphal apices of the fungus Neurospora crassa. Fungal Genet Biol (2000) 0.76
Novel ion channels in the protists, Mougeotia and Saprolegnia, using sub-gigaseals. FEBS Lett (1992) 0.76
Mycoplasma-like structures in the aquatic fungus Aphanomyces astaci. Science (1974) 0.76
Temporal analysis of the nuclear cycle by serial section electron microscopy of the fungus, Saprolegnia ferax. Eur J Cell Biol (1980) 0.76
[Radioimmunoassay for parathyroid hormone and its clinical application (author's transl)]. Horumon To Rinsho (1981) 0.75
[Studies of caries prevention in school health program. 2. Concentration of urinary fluoride following the use of fluoride mouth rinsing]. Gifu Shika Gakkai Zasshi (1979) 0.75
[Studies of caries prevention in school health program. 3. Application of caries activity test: improved Snyder test (author's transl)]. Gifu Shika Gakkai Zasshi (1980) 0.75
A comparison of techniques for localizing actin and tubulin in hyphae of Saprolegnia ferax. J Histochem Cytochem (1994) 0.75
Chytridiomycetous gut fungi, oft overlooked contributors to herbivore digestion. Can J Microbiol (1993) 0.75
[Studies of caries prevention in school health program. 1. Multiple caries-preventive procedure and effects in small scale school]. Gifu Shika Gakkai Zasshi (1979) 0.75
Ca(2+)-dependent polarization of axis establishment in the tip-growing organism, Saprolegnia ferax, by gradients of the ionophore A23187. Eur J Cell Biol (1995) 0.75
Managing a patient with an infected pacemaker site. Nurs Times (2001) 0.75
[Thyroid cancer and calcospherites: report on the detection of minute cancer of the thyroid gland. 1]. Iryo (1967) 0.75